Access to Defibrotide (USA)

Defibrotide is available to patients in the United States through a Gentium sponsored Expanded Access, Treatment IND Protocol, Protocol 2006-05.

"Details of the protocol including a list of centers in the United States active in the study can be found on clinicaltrials.gov, NCT00628498".